{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:03:24Z","timestamp":1793624604757,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["P01AI165066"],"award-info":[{"award-number":["P01AI165066"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016255","name":"Inovio Pharmaceuticals Inc","doi-asserted-by":"publisher","award":["SRA 21-05"],"award-info":[{"award-number":["SRA 21-05"]}],"id":[{"id":"10.13039\/100016255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001340","name":"W. W. Smith Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.xcrm.2025.102035","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T09:11:02Z","timestamp":1742634662000},"page":"102035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6752-3402","authenticated-orcid":false,"given":"Nicholas J.","family":"Tursi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachchidanand","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bedanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitha","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Parzych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen","family":"Okba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"S\u00e1rk\u00f6zy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ibanez","family":"Trullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony N.","family":"Gary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Vadovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Laenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Londregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Suhail","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Omo-Lamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Blatney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Hojecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Maricic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor R.F.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent M.","family":"Humeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102035_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2025.102035_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1880","article-title":"Gene-encoded nanoparticle vaccine platforms for in\u00a0vivo assembly of multimeric antigen to promote adaptive immunity","volume":"15","author":"Tursi","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.xcrm.2025.102035_bib3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases \u2014 advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102035_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.xcrm.2025.102035_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.xcrm.2025.102035_bib6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102035_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102035_bib10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.xcrm.2025.102035_bib11","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102035_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/vaccines9020081","article-title":"Development of mRNA Vaccines: Scientific and Regulatory Issues","volume":"9","author":"Knezevic","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2025.102035_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-0716-3770-8_7","article-title":"Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases","volume":"2786","author":"Vadovics","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102035_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102035_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and Immunogenicity of an Anti\u2013Zika Virus DNA Vaccine","volume":"385","author":"Tebas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100689","article-title":"Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial","volume":"31","author":"Tebas","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.xcrm.2025.102035_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102035_bib21","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102035_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.571030","article-title":"Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases","volume":"2","author":"Xu","year":"2020","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.xcrm.2025.102035_bib23","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/lary.30749","article-title":"Interim Results of a Phase 1\/2 Open-Label Study of INO-3107 for HPV-6 and\/or HPV-11-Associated Recurrent Respiratory Papillomatosis","volume":"133","author":"Mau","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.xcrm.2025.102035_bib24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102035_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113605","article-title":"DNA Vaccines-How Far From Clinical Use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102035_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"De Rosa","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102035_bib29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-22-1987","article-title":"Safety and\u00a0Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent\/Metastatic Head and Neck Squamous Cell Carcinoma","volume":"29","author":"Aggarwal","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102035_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081698","article-title":"Efficient Delivery of DNA Using Lipid Nanoparticles","volume":"14","author":"Cui","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2025.102035_bib31","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102035_bib32","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1039\/D2BM00168C","article-title":"In\u00a0vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression","volume":"10","author":"Algarni","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.xcrm.2025.102035_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101169","article-title":"Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters","volume":"32","author":"Liao","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102035_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41467-024-44830-1","article-title":"Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models","volume":"15","author":"Guimaraes","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102035_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100787","article-title":"A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients","volume":"33","author":"Ljungman","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.xcrm.2025.102035_bib36","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.90.9.4156","article-title":"Gene inoculation generates immune responses against human immunodeficiency virus type 1","volume":"90","author":"Wang","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102035_bib37","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102035_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/17425247.1.1.127","article-title":"Intracellular trafficking of nucleic acids","volume":"1","author":"Zhou","year":"2004","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.xcrm.2025.102035_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.xcrm.2025.102035_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-60327-198-1_6","article-title":"Zeta potential measurement","volume":"697","author":"Clogston","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102035_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.xcrm.2025.102035_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52687","article-title":"Squalene emulsion-based vaccine adjuvants stimulate CD8 T\u00a0cell, but not antibody responses, through a RIPK3-dependent pathway","volume":"9","author":"Kim","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2025.102035_bib43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20091627","article-title":"Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8\u03b1+ conventional dendritic cells","volume":"207","author":"Edelson","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib44","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41467-020-15375-w","article-title":"Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity","volume":"11","author":"Seo","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102035_bib45","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/MCB.01202-13","article-title":"Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation","volume":"34","author":"Levanon","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102035_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02969","article-title":"TRAF1 Signaling in Human Health and Disease","volume":"9","author":"Edilova","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib47","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.4049\/jimmunol.171.11.6052","article-title":"Cross-Talk in the Innate Immune System: Neutrophils Instruct Recruitment and Activation of Dendritic Cells during Microbial Infection 1","volume":"171","author":"Bennouna","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib48","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood-2017-04-777680","article-title":"The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage","volume":"130","author":"Del Prete","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102035_bib49","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8057","article-title":"CD244(+) polymorphonuclear myeloid-derived suppressor cells reflect the status of peritoneal dissemination in a colon cancer mouse model","volume":"45","author":"Sugita","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.xcrm.2025.102035_bib50","article-title":"Glycosyltransferase Extl1 promotes CCR7-mediated dendritic cell migration to restrain infection and autoimmunity","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102035_bib51","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102035_bib52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41577-024-00991-0","article-title":"New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells","volume":"24","author":"Fooksman","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102699","article-title":"A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens","volume":"24","author":"Gary","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2025.102035_bib55","article-title":"Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in\u00a0vivo","volume":"3","author":"Gary","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2025.102035_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1138609","article-title":"Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge","volume":"14","author":"Gary","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib57","article-title":"Neutralizing antibodies targeting SARS-CoV-2 spike protein","volume":"50","author":"Xiaojie","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xcrm.2025.102035_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102035_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-022-00511-y","article-title":"mRNA vaccines induce rapid antibody responses in mice","volume":"7","author":"Gebre","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.xcrm.2025.102035_bib60","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3390\/vaccines11101580","article-title":"The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice","volume":"11","author":"Zhang","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2025.102035_bib61","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mabi.201300046","article-title":"The effect of N\/P ratio on the in\u00a0vitro and in\u00a0vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes","volume":"13","author":"Gary","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.xcrm.2025.102035_bib62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib63","article-title":"In\u00a0Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity","volume":"7","author":"Xu","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2025.102035_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N1-methylpseudouridylation of mRNA causes\u00a0+1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102035_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/d41586-023-03787-9","article-title":"Modified messenger-RNA components alter the encoded protein","volume":"625","author":"Tursi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102035_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9020108","article-title":"Advancements in mRNA Encoded Antibodies for Passive Immunotherapy","volume":"9","author":"Deal","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.xcrm.2025.102035_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40259-020-00412-3","article-title":"In\u00a0Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies","volume":"34","author":"Patel","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.xcrm.2025.102035_bib79","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102035_bib80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib69","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102035_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102035_bib70","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102035_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2005.12.955","article-title":"Plasmacytoid Dendritic Cell Recruitment to Murine Lung During Paramyxoviral Infection is Type I Ifn Receptor Dependent","volume":"117","author":"Joo","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib72","article-title":"Analysis of Myeloid Cells in Mouse Tissues with Flow Cytometry","volume":"1","author":"Liu","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2025.102035_bib73","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation1","volume":"179","author":"Haynes","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib74","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.immuni.2008.07.016","article-title":"Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis","volume":"29","author":"Hao","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102035_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1997.8218","article-title":"Selective modulation of T\u00a0cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment","volume":"146","author":"Gerberick","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102035_bib76","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.4049\/jimmunol.180.12.8299","article-title":"The central memory CD4+ T\u00a0cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma","volume":"180","author":"Pakpour","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib81","first-page":"e51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2025.102035_bib82","article-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge","volume":"8","author":"Jacobsen","year":"2017","journal-title":"Model. mBio."},{"key":"10.1016\/j.xcrm.2025.102035_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1072810","article-title":"Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in\u00a0vivo","volume":"14","author":"Tursi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102035_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125001089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125001089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:37:14Z","timestamp":1769056634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125001089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2666379125001089"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102035","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102035"}}